In FIGO III–IV stage and in mutant p53 ovarian cancer samples, CCDC106, p53 and ATF4 were positively expressed in the nucleus and cytoplasm, respectively, while p21 was weakly expressed in FIGO III–IV stage and in mutant p53 ovarian cancer samples (Figure 9). Here, CCDC106 is linked to ovarian carcinoma.